BRAF mutations are detectable in conjunctival but not uveal melanomas
- PMID: 15577314
- DOI: 10.1097/00008390-200412000-00003
BRAF mutations are detectable in conjunctival but not uveal melanomas
Abstract
Activating mutations in exon 15 of BRAF have been detected in a high proportion of cutaneous melanomas. To determine whether such mutations are a feature of conjunctival or uveal melanomas, we screened DNA from these tumours. Twenty-one conjunctival and 88 uveal tumours were included in the study. Mutation analysis of BRAF exons 11 and 15 was undertaken using a combination of conformationally sensitive gel electrophoresis and direct sequencing. Mutations in exon 15 were detected in three of the conjunctival tumours (two V599E and one E585 K). None of the uveal tumours possessed a BRAF mutation in either exon 15 or 11. We conclude that uveal melanomas arise independently of oncogenic BRAF mutations, but the development of a proportion of conjunctival tumours involves mutation of this gene.
Similar articles
-
BRAF mutations in conjunctival melanoma.Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2484-8. doi: 10.1167/iovs.04-0093. Invest Ophthalmol Vis Sci. 2004. PMID: 15277467
-
Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.Acta Ophthalmol. 2016 May;94 Thesis 1:1-27. doi: 10.1111/aos.13100. Acta Ophthalmol. 2016. PMID: 27192168
-
T1799A BRAF mutations in conjunctival melanocytic lesions.Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3027-30. doi: 10.1167/iovs.04-1449. Invest Ophthalmol Vis Sci. 2005. PMID: 16123397
-
BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.J Clin Pathol. 2005 Jun;58(6):640-4. doi: 10.1136/jcp.2004.022509. J Clin Pathol. 2005. PMID: 15917418 Free PMC article. Review.
-
Genetic Biomarkers in Melanoma of the Ocular Region: What the Medical Oncologist Should Know.Int J Mol Sci. 2020 Jul 23;21(15):5231. doi: 10.3390/ijms21155231. Int J Mol Sci. 2020. PMID: 32718045 Free PMC article. Review.
Cited by
-
Management Issues in Conjunctival Tumours: Conjunctival Melanoma and Primary Acquired Melanosis.Ophthalmol Ther. 2019 Dec;8(4):501-510. doi: 10.1007/s40123-019-00219-8. Epub 2019 Nov 6. Ophthalmol Ther. 2019. PMID: 31691901 Free PMC article. Review.
-
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.PLoS One. 2015 Mar 11;10(3):e0118564. doi: 10.1371/journal.pone.0118564. eCollection 2015. PLoS One. 2015. PMID: 25761109 Free PMC article. Clinical Trial.
-
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma.Front Oncol. 2019 Apr 5;9:232. doi: 10.3389/fonc.2019.00232. eCollection 2019. Front Oncol. 2019. PMID: 31024839 Free PMC article.
-
Metastatic Cutaneous Melanoma Presenting with Choroidal Metastasis Simulating Primary Uveal Melanoma.Ocul Oncol Pathol. 2019 Feb;5(2):135-138. doi: 10.1159/000488708. Epub 2018 Aug 8. Ocul Oncol Pathol. 2019. PMID: 30976593 Free PMC article.
-
Genetic Aspects of Conjunctival Melanoma: A Review.Genes (Basel). 2023 Aug 23;14(9):1668. doi: 10.3390/genes14091668. Genes (Basel). 2023. PMID: 37761808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials